“…Understanding the human glycome comprises a crucial portion of cancer research since targeting cancerrelated glycan structures is quickly emerging as an effective diagnostic method [78][79][80]. In this context, several studies have reported on the use of lectins to map changes in the glycosylation patterns of malignant cells, making it possible to follow and predict the progression of the disease and the degree of malignancy [55,[81][82][83][84][85][86]. To accomplish this, several well-known techniques can be used, including, for example, Enzyme-Linked Lectin Assay (ELLA) [87,88], immunohistochemistry [89][90][91], lectin nanoparticle assays [92], glyco-functionalized quantum dots (QDs) with lectins [93], lectin blot analysis [58,94], lectins conjugated with fluoro-microbeads and antibody-lectin sandwich assay [87,95], SDS-PAGE/Western Blotting [96], and fluorescent labeling techniques [97,98], among others [99][100][101].…”